 |
|
|
| |
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Women
|
| |
| |
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
Cissy Kityo,1 Debbie Hagins,2 Ellen Koenig,3 Anchelee Avihingsanon,4 Ploenchan Chetchotisakd,5 Khuanchai Supparatpinyo,6 Natalya Gankina,7
Vadim Pokrovsky,8 Evgenly Voronin,9 Jeffrey L. Stephens,10 Edwin DeJesus,11 Hui Wang,12 Erin Quirk,12 Hal Martin,12 Tariro Makadzange12
1Joint Clinical Research Centre, Kampala, Uganda; 2Georgia Department of Public Health, Coastal Health District, Chatham CARE Center, Savannah, GA; 3Zona Universitaria/Instituto Dominicano de Estudios Virológicos, Santo Domingo, Dominica Republic; 4The HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Centre, Bangkok, Thailand; 5Srinagarind Hospital, Khon Kaen, Thailand; 6Chiang Mai University, Chiang Mai, Thailand;
7Krasnoyarsk Territorial Center for Prevention and Control of AIDS and Infectious Diseases, Krasnoyarsk, Russia; 8Center for Prevention and Control of AIDS, Moscow, Russia; 9Federal Budgetary Institution "Republican Clinical Infectious Hospital" of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia; 10Mercer University School of Medicine, Macon, GA; 11Orlando Immunology Center, Orlando, FL; 12Gilead Sciences, Inc., Foster City, CA
References
1. UNAIDS. Fact Sheet-World AIDS Day 2017.
www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf; 2. AIDSinfo. http://www.aidsinfo.nih.gov/
ContentFiles/AdultandAdolescentGL.pdf; EACS. http://www.eacsociety.org/files/guidelines_8.2-english.pdf;
3. European AIDS Clinical Society. http://www.eacsociety.org/fi
les/2015_eacsguidelines_8.0-english_rev-20151221.pdf;
4. Gunthard HF, et al. JAMA 2016;316:191-210;
5. Tsiang M, et al. Antimicrob Agents Chemother 2016;60:7086-97;
6. Arribas JR, et al. J Acquir Immune Defic Syndr 2017;75:211-8;
7. Gallant JE, et al. J Acquir Immune Defic Syndr 2017;75:61-6; 8. Gallant JE, et al. Lancet 2017;390:2063-72;
9. Sax PE, et al. Lancet 2017;390:2073-82.
|
| |
|
|
|
|
|
